Published in Virology on January 20, 1997
Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R Peptide. J Virol (2003) 1.48
Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex. J Virol (1998) 1.33
Palmitoylation of the murine leukemia virus envelope protein is critical for lipid raft association and surface expression. J Virol (2002) 1.16
Comprehensive mutational analysis of the Moloney murine leukemia virus envelope protein. J Virol (2001) 1.08
Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide. J Virol (2001) 0.98
Characterization of a cytolytic strain of equine infectious anemia virus. J Virol (2003) 0.90
Two distinct mechanisms regulate recruitment of murine leukemia virus envelope protein to retroviral assembly sites. Virology (2010) 0.87
Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion. J Virol (2006) 0.87
G541R within the 4070A TM protein regulates fusion in murine leukemia viruses. J Virol (2003) 0.79
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene (2001) 4.40
Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer (1998) 2.39
Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut (2005) 2.31
Analysis of retroviral pol gene products with antisera raised against fusion proteins produced in Escherichia coli. J Virol (1986) 2.18
Mutational analysis of the envelope gene of Moloney murine leukemia virus. J Virol (1993) 2.08
Purification and characterization of murine retroviral reverse transcriptase expressed in Escherichia coli. J Biol Chem (1985) 2.02
Analysis of long terminal repeat circle junctions of human immunodeficiency virus type 1. J Virol (1990) 1.80
Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of Moloney murine leukemia virus. J Virol (1992) 1.64
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res (2000) 1.50
Clearing of melanoma in situ with intralesional interferon alfa in a patient with xeroderma pigmentosum. Arch Dermatol (1994) 1.46
Characterization of the forward and reverse integration reactions of the Moloney murine leukemia virus integrase protein purified from Escherichia coli. J Biol Chem (1993) 1.44
Specificity of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H in removal of the minus-strand primer, tRNA(Lys3). J Biol Chem (1992) 1.44
CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. J Immunol (1996) 1.42
Analysis of bacteriophage phi X174 gene A protein-mediated termination and reinitiation of phi X DNA synthesis. II. Structural characterization of the covalent phi X A protein-DNA complex. J Biol Chem (1984) 1.41
Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol (1994) 1.36
Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China. Gut (2005) 1.32
High levels of carcinogenic polycyclic aromatic hydrocarbons present within food from Linxian, China may contribute to that region's high incidence of oesophageal cancer. Eur J Cancer (1998) 1.30
RNase H cleavage of tRNAPro mediated by M-MuLV and HIV-1 reverse transcriptases. Virology (1997) 1.25
Role of the His-Cys finger of Moloney murine leukemia virus integrase protein in integration and disintegration. J Virol (1993) 1.25
Studies of esophageal balloon cytology in Linxian, China. Cancer Epidemiol Biomarkers Prev (1997) 1.23
Contributions of DNA polymerase subdomains to the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase. J Virol (1994) 1.21
Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer. Clin Cancer Res (1999) 1.20
Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain. J Virol (1993) 1.19
Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population. Genes Chromosomes Cancer (2000) 1.19
Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin Cancer Res (2001) 1.14
Development of a urinary biomarker of human exposure to deoxynivalenol. Food Chem Toxicol (2003) 1.12
Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses. J Virol (2000) 1.09
Characterization of chimeras between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A envelope proteins. J Virol (1996) 1.07
Divalent cation modulation of the ribonuclease functions of human immunodeficiency virus reverse transcriptase. Biochemistry (1995) 1.07
Analysis of cysteine mutations on the transmembrane protein of Moloney murine leukemia virus. Virology (1995) 1.03
Functional domains of Moloney murine leukemia virus integrase defined by mutation and complementation analysis. J Virol (1996) 1.01
High frequency allelic loss on chromosome 17p13.3-p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China. Carcinogenesis (2000) 1.01
RNA capping by the vaccinia virus guanylyltransferase. Structure of enzyme-guanylate intermediate. J Biol Chem (1984) 1.00
Polycyclic aromatic hydrocarbons identified in soot extracts from domestic coal-burning stoves of Henan Province, China. Environ Sci Technol (2001) 0.99
RNase H requirements for the second strand transfer reaction of human immunodeficiency virus type 1 reverse transcription. J Virol (1999) 0.97
Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey. Anticancer Res (1999) 0.97
Influence of substrate structure on disintegration activity of Moloney murine leukemia virus integrase. J Virol (1993) 0.97
Functional characterization of the N termini of murine leukemia virus envelope proteins. J Virol (2001) 0.91
Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction. Acta Cytol (1994) 0.89
von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens. Hum Pathol (1996) 0.88
Assembly and catalysis of concerted two-end integration events by Moloney murine leukemia virus integrase. J Virol (2001) 0.88
Expression of cyclooxygenase-2 in human adenocarcinomas of the gastric cardia and corpus. Oncol Rep (1999) 0.87
Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern China. Cancer Detect Prev (2003) 0.87
Analysis of bacteriophage phi X174 gene A protein-mediated termination and reinitiation of phi X DNA synthesis. I. Characterization of the termination and reinitiation reactions. J Biol Chem (1984) 0.86
Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein. Cancer Res (1995) 0.85
Coordinated disintegration reactions mediated by Moloney murine leukemia virus integrase. J Virol (1996) 0.82
Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity. J Mol Biol (2001) 0.82
Detection of adrenomedullin, a hypotensive peptide, in amniotic fluid and fetal membranes. Am J Obstet Gynecol (1996) 0.82
Functional interactions of the HHCC domain of moloney murine leukemia virus integrase revealed by nonoverlapping complementation and zinc-dependent dimerization. J Virol (1999) 0.82
Implication of a central cysteine residue and the HHCC domain of Moloney murine leukemia virus integrase protein in functional multimerization. J Virol (1998) 0.82
Differential effects of C-terminal molecular tagged integrase on replication competent moloney murine leukemia virus. Virology (2000) 0.81
Sequence requirements for removal of tRNA by an isolated human immunodeficiency virus type 1 RNase H domain. J Virol (1998) 0.81
Mutational analysis of the N-terminus of Moloney murine leukemia virus integrase. Virology (2001) 0.81
Allelic loss on chromosome bands 13q11-q13 in esophageal squamous cell carcinoma. Genes Chromosomes Cancer (2001) 0.81
Specificity of priming reaction of HIV-1 reverse transcriptase, 2'-OH or 3'-OH. J Biol Chem (1994) 0.81
Analysis of a temperature-sensitive mutation affecting the integration protein of Moloney murine leukemia virus. Virology (1993) 0.81
Plasma immunotherapy in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J (1993) 0.79
A comparative study of the aerosolized bronchodilators, isoproterenol, metaproterenol and terbutaline in asthma. Ann Allergy (1977) 0.79
Analysis of messenger ribonucleic acid and protein for the ligands and receptors of the platelet-derived growth factor signaling pathway in the placenta, extraembryonic membranes, and uterus during the latter half of murine gestation. Endocrinology (1995) 0.77
Comparison of second-strand transfer requirements and RNase H cleavages catalyzed by human immunodeficiency virus type 1 reverse transcriptase (RT) and E478Q RT. J Virol (2000) 0.75
A low-cost, reliable, and accurate general-purpose timer. J Exp Anal Behav (1967) 0.75
Quality assurance. J Psychosoc Nurs Ment Health Serv (1988) 0.75
Human pulmonary acinar aplasia: reduction of transforming growth factor-beta ligands and receptors. Pediatr Res (1999) 0.75
OR sterility for total hip replacement. AORN J (1972) 0.75
A common sense approach to investing for income. CDS Rev (1992) 0.75
Assays for retroviral RNase H. Methods Enzymol (2001) 0.75
Changes to the quantity and processing of starchy foods in a western diet can increase polysaccharides escaping digestion and improve in vitro fermentation variables. Br J Nutr (2000) 0.75